albumin binder

Open Access
Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy
Mengxin Xu, Pu Zhang, Jie Ding, Junyi Chen, Li Huo and Zhibo Liu

Journal of Nuclear Medicine June 1, 2022, 63 (6) 952-958; DOI: https://doi.org/10.2967/jnumed.121.262533
You have access
¹⁷⁷Lu-Labeled Albumin-Binder–Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio
Hsiou-Ting Kuo, Kuo-Shyan Lin, Zhengxing Zhang, Carlos F. Uribe, Helen Merkens, Chengcheng Zhang and François Bénard

Journal of Nuclear Medicine April 1, 2021, 62 (4) 521-527; DOI: https://doi.org/10.2967/jnumed.120.250738
You have access
DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid–Targeted ¹⁷⁷Lu-Radionuclide Tumor Therapy in Mice
Cristina Müller, Harriet Struthers, Christian Winiger, Konstantin Zhernosekov and Roger Schibli

Journal of Nuclear Medicine January 1, 2013, 54 (1) 124-131; DOI: https://doi.org/10.2967/jnumed.112.107235

Main menu